These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34400971)

  • 1. Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease.
    Di Serafino L; Magliulo F; Esposito G
    Interv Cardiol; 2021 Apr; 16():e24. PubMed ID: 34400971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.
    De Backer O; Lønborg J; Helqvist S; Warnøe J; Kløvgaard L; Holmvang L; Pedersen F; Tilsted HH; Raungaard B; Jørgensen E; Køber L; Høfsten DE; Kelbæk H; Engstrøm T
    EuroIntervention; 2019 Jun; 15(2):172-179. PubMed ID: 30666962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials.
    Sarathy K; Nagaraja V; Kapur A; Szirt R; Raval J; Eslick GD; Burgess D; Denniss AR
    Heart Lung Circ; 2015 Apr; 24(4):327-34. PubMed ID: 25547531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials.
    Kowalewski M; Schulze V; Berti S; Waksman R; Kubica J; Kołodziejczak M; Buffon A; Suryapranata H; Gurbel PA; Kelm M; Pawliszak W; Anisimowicz L; Navarese EP
    Heart; 2015 Aug; 101(16):1309-17. PubMed ID: 26037102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction.
    Banning AS; Gershlick AH
    Curr Cardiol Rep; 2015 Sep; 17(9):632. PubMed ID: 26238745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Thomas MP; Bates ER
    Curr Opin Cardiol; 2017 Nov; 32(6):755-760. PubMed ID: 28759470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial.
    Smits PC; Laforgia PL; Abdel-Wahab M; Neumann FJ; Richardt G; Boxma-de Klerk B; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Frederix GW; Omerovic E
    EuroIntervention; 2020 Jun; 16(3):225-232. PubMed ID: 32250250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis.
    Qiao Y; Li W; Mohamed S; Nie S; Du X; Zhang Y; Jia C; Wang X; Liu X; Ma C
    EuroIntervention; 2015 Sep; 11(5):525-32. PubMed ID: 26390516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of non culprit coronary artery lesions in patients with ST segment elevated myocardial infarction and multivessel disease by control angiography with quantitative coronary angiography.
    Dönmez E; Koç M; Şeker T; İçen YK; Çayli M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1471-6. PubMed ID: 27448213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of complete versus incomplete revascularisation of patients with STEMI with multivessel coronary artery disease: an observational study.
    Dimitriu-Leen AC; Hermans MP; Veltman CE; van der Hoeven BL; van Rosendael AR; van Zwet EW; Schalij MJ; Delgado V; Bax JJ; Scholte AJ
    Open Heart; 2017; 4(1):e000541. PubMed ID: 28409009
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.